Home Newsfeeds Scotiabank Downgrades Braskem to Sector Underperform

Scotiabank Downgrades Braskem to Sector Underperform

Scotiabank analyst Ben Isaacson downgrades Braskem (NYSE:BAK) from Sector Perform to Sector Underperform.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Scotiabank analyst Ben Isaacson downgrades Braskem (NYSE:BAK) from Sector Perform to Sector Underperform.

Axcella Health Will Be Issued U.S. Patent Number 11,571,404 Tomorrow Titled “Compositions And Methods For The Treatment Of Liver Diseases And Disorders Associated With One Or Both Of Hyperammonemia Or Muscle Wasting”

By Happy Mohamed

February 6, 2:18 PM

https://twitter.com/PatentGrants/status/1622660323923890177

AXLA

Mizuho Upgrades Pentair to Buy, Raises Price Target to $60

By Benzinga Newsdesk

January 13, 7:42 AM

Mizuho analyst Brett Linzey upgrades Pentair (NYSE:PNR) from Neutral to Buy and raises the price target from $44 to $60.

PNR

What’s Going On With Intel Stock Friday?

By Anusuya Lahiri

December 15, 8:06 AM

Intel Corp's (NASDAQ: INTC) CEO, Pat Gelsinger, announced that the company will not be spinning off its

INTC

PayPal Analysts Increase Price Targets Following Earnings Report, Elliott Management’s $2B Investment

By Chris Katje

August 3, 11:48 AM

Analysts are diving into the second quarter earnings report from PayPal Holdings (NASDAQ: PYPL) and evaluating what a $2 billion stake from Elliott Management could mean for the financial technology company's future.

EBAY

Scotiabank Downgrades Braskem to Sector Underperform

Related Posts

Axcella Health Will Be Issued U.S. Patent Number 11,571,404 Tomorrow Titled “Compositions And Methods For The Treatment Of Liver Diseases And Disorders Associated With One Or Both Of Hyperammonemia Or Muscle Wasting”

Mizuho Upgrades Pentair to Buy, Raises Price Target to $60

What’s Going On With Intel Stock Friday?

PayPal Analysts Increase Price Targets Following Earnings Report, Elliott Management’s $2B Investment